Sickle Cell Data Collection Program: Three-Year Dissemination and Analysis Plan for Georgia by Georgia Health Policy Center
Georgia State University 
ScholarWorks @ Georgia State University 
GHPC Reports Georgia Health Policy Center 
6-30-2017 
Sickle Cell Data Collection Program: Three-Year Dissemination 
and Analysis Plan for Georgia 
Georgia Health Policy Center 
Follow this and additional works at: https://scholarworks.gsu.edu/ghpc_reports 
Recommended Citation 
Georgia Health Policy Center, "Sickle Cell Data Collection Program: Three-Year Dissemination and 
Analysis Plan for Georgia" (2017). GHPC Reports. 7. 
https://scholarworks.gsu.edu/ghpc_reports/7 
This Article is brought to you for free and open access by the Georgia Health Policy Center at ScholarWorks @ 
Georgia State University. It has been accepted for inclusion in GHPC Reports by an authorized administrator of 
ScholarWorks @ Georgia State University. For more information, please contact scholarworks@gsu.edu. 
Sickle Cell Data 
Collection Program: 
Three-Year Dissemination and 









 Sickle Cell Disease Overview……………………………………………………………………………………........6
 Past Sickle Cell Disease Surveillance……………………………………………………………...................10
   
Sickle	Cell	Data	Collection	Program	in	Georgia………………………………………………………………………..17
 
















































Georgia Health Policy Center
5












































































Georgia Health Policy Center
7


































































































































































Georgia Health Policy Center
11














































Georgia Health Policy Center
13
 Demographics
• There are 7,299 people in Georgia living with SCD (confirmed and probable cases).
• People with SCD live in almost every county throughout Georgia.
• Those living with SCD in Georgia range in age from newborns to people over 70 years old.
• The vast majority (97% or more) of Georgia newborns with SCD are black or African-American, while 
approximately 2% are Hispanic.
• Roughly one out of every 295 black or African-American babies born in Georgia from 2004 through 
2008 had some form of SCD.
Figure 3. Number of Individuals with SCD by County






























• There are documented health care visits for 94% of the identified 7,299 Georgia residents with SCD 
between 2004 and 2008.
• Of newborns with a positive screen for SCD from 2004 through 2008, 80% were later seen at one of 
Georgia’s two pediatric sickle cell centers.
• For 26% of individuals with SCD, there were no hospitalizations during the five-year period, and 16% 
had no ED visits.
• Hospital visits, especially those to the ED, increased considerably after childhood. Children aged 0-19 
years averaged four ED visits over the five years, while those aged 20-49 years had more than 15 



















































• Across data sets, 4,288 Level 1 (confirmed), 3,011 Level 2 (probable), and 9,208 (possible) cases were 
identified in Georgia from 2004 through 2008.1 
• The majority (88%) of the 828 newborns who screened positive for sickle cell disease from 2004 
through 2008 had a documented confirmatory diagnosis at follow-up (Level 1 case). The remaining 98 
cases with positive screens, but no confirmatory test, were categorized as Level 2.
Provider information61
Based on surveys completed with 100 primarily pediatric medical practices in 48 counties that, according 
to RuSH data, contain 85% of all confirmed SCD cases in Georgia:
• SCD patients were seen in 84 of 100 surveyed medical practices;
• Only seven practices had a sickle cell specialist on staff;
• Most respondents said they refer their patients with SCD to specialists to manage all aspects of sickle 
cell care; however
• Sixteen respondents said there was no such specialist within a one-hour drive, or they were not 
 aware of one.
Health care utilization32
• Hydroxyurea was underutilized in Georgia from 2004 to 2008:
 □ Among confirmed cases with SCD types for which hydroxyurea has demonstrated benefit, the 
portion meeting clinical criteria who received hydroxyurea was 38% (36% of children, 42% of 
adults); and
 □ Overall, only 30% of individuals (29% of children, 32% of adults) who met the clinical criteria for 
hydroxyurea treatment filled a prescription.
• Initiation of TCD ultrasound screening and pneumococcal polysaccharide vaccination (PPV) in children 
from 2004 to 2008 is suboptimal in Georgia:
 □ In a cohort of 125 Georgia toddlers with SCD, 77% received their first dose of PPV vaccine at 2 
years of age; and
 □ Only 23% of these same toddlers received their first TCD screening for stroke risk at 2 years of 
age, as recommended.
Validation studies32
• Claims data appears useful to track use of TCD in children and yields similar results to chart review.
• State-based immunization registries are the most complete source of tracking immunizations for 
individuals with SCD, better than chart review and claims data.
• Validation studies of the RuSH case definition found that a simpler definition of at least three SCD-
coded encounters was just as effective as the original definition (two encounters with SCD diagnosis 
codes and at least one encounter with an SCD-associated treatment, procedure, or complication) in 
accurately identifing “probable cases” and reducing the number of missed cases.
• Based on a five-year surveillance period, using this updated case definition of at least three SCD-
coded encounters to identify SCD in administrative data is 97% accurate in identifying true cases 
while only missing approximately 4% of cases.62 
Key Findings from Georgia PHRESH Work:60
Key Findings from Georgia PHRESH Work:60



























































Transition from pediatric to adult care
SCDC	data	includes	information	on	utilization	(i.e.,	how	many	times	a	patient	visits	specific	types	of	providers	
or	settings,	treatments,	and	procedures)	and	health	outcomes	for	most	patients	within	a	state,	whether	or	not	
















National SCDC Priority Areas
  Aging population
  Geography of population














































































stakeholders have roles throughout the cycle.
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Fitting SCD priorities in the national health reform landscape
Efforts	are	underway	locally,	regionally,	and	nationally	to	transform	the	health	care	system	to	be	more	efficient,	
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Target	SCD	patient	and	family	education	in	parts	of	state	with	high	SCD	prevalence,	
high	SCD-related	mortality,	high	complication	rates,	or	unusual	utilization	patterns	
	 	 	 	 	
Target	high-incidence	areas	for	trait	education	and	screening	
	 	 	 	 	
Target	culturally,	linguistically,	and	topically	appropriate	patient	outreach	and	
education	based	on	patient	demographics	by	geography	





	 	 	 	 	
Decide	allocation	of	outpatient	resources/hours	based	on	the	most	frequent	
presenting	reasons	for	ED	visits/hospitalizations	
	 	 	 	 	
Decide	location	and	hours	of	specialty	clinics	and	establishment	of	telehealth	
capabilities	based	on	accessibility	of	care	facilities	across	the	acuity	spectrum	
	 	 	 	 	
Payers	
Decide	quality	measures	to	reflect	evidence-based	practices	
	 	 	 	 	
Target	transition-appropriate	information	on	health,	benefits,	and	referrals	based	on	
areas	of	highest	transition-aged	populations	








	 	 	 	 	
Decide	workforce	development	incentives	to	reduce	provider-patient	gaps	by	
geography	
	 	 	 	 	
Target	benefits	counseling	and	referrals	for	parents	of	newborns,	transition-age	
patients,	and	adult	patients	based	on	incidence/prevalence	distributions	by	age	




	 	 	 	 	
Decide	referral	strategies	based	on	location	of	specialists	and	SCD	care	providers	
	 	 	 	 	
Target	culturally,	linguistically,	and	topically	appropriate	provider	education	based	
on	demographics	by	geography	
	 	 	 	 	
	











Table 2. Three-Year Georgia SCDC Data Outputs 
















































Geography	of	patient	demographics	(age,	race/ethnicity,	language)		 	 	 	 	 	
Geography	of	utilization	(areas	of	high	incidence,	prevalence,	
mortality,	and/or	utilization)	
	 	 	 	 	
Geography	of	providers	(locations	of	SCD	care	providers	and	
specialists;	care	facilities	across	the	acuity	spectrum)	
	 	 	 	 	
Most	frequent	presenting	reasons	for	emergency	visits	and	
hospitalizations	
	 	 	 	 	
Quality	measures	for	evidence-based	practices	 	 	 	 	 	
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Decisions on health 
insurance coverage 
extensions	for	young	





































Table 3. Priority Analysis Topics by Action and Priority Area
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• What are the trends	over	time	in	providers’	adherence	to	recommended	practices?	Are	there	commonly	
used	treatments	that	are	not	associated	with	better	outcomes?	Do	new	treatments	have	long-term	
implications	for	mortality	and	other	outcomes?
• How is it	best	to	manage	the	needs	of	dual	beneficiaries?
30
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Appendix b: Undistilled Georgia SCDC Priorities 
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